Opko Health OPK
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 26th percentile, 5-year average -8.3x
Near the top of its 5-year range · 87th percentile, 5-year average 0.9x
#1634 of 5329 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 96th percentile, 5-year average 1.4x
#2490 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.12 | – | 0.86 | 87% (pricier than usual) | #1634 of 5329 (1 = cheapest) |
| PE | -8.40 | 14.56 | -8.27 | 26% (cheaper than usual) | – |
| PS | 1.91 | 3.87 | 1.38 | 96% (pricier than usual) | #2490 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on OPK.
Sign in to join the discussion.